ES416929A1 - Procedimiento para la preparacion de derivados de 1-(3-(5, 6,7,8-tetrahidronaft-1-il-oxi)-propil)-piperazina. - Google Patents

Procedimiento para la preparacion de derivados de 1-(3-(5, 6,7,8-tetrahidronaft-1-il-oxi)-propil)-piperazina.

Info

Publication number
ES416929A1
ES416929A1 ES416929A ES416929A ES416929A1 ES 416929 A1 ES416929 A1 ES 416929A1 ES 416929 A ES416929 A ES 416929A ES 416929 A ES416929 A ES 416929A ES 416929 A1 ES416929 A1 ES 416929A1
Authority
ES
Spain
Prior art keywords
tetrahydronaphth
yloxy
propyl
novel
therapeutic compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES416929A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of ES416929A1 publication Critical patent/ES416929A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES416929A 1972-07-20 1973-07-14 Procedimiento para la preparacion de derivados de 1-(3-(5, 6,7,8-tetrahidronaft-1-il-oxi)-propil)-piperazina. Expired ES416929A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2235597A DE2235597A1 (de) 1972-07-20 1972-07-20 1-eckige klammer auf 3-(5,6,7,8tetrahydronaphth-1-yl-oxy) -propyl eckige klammer zu -piperazin-derivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
ES416929A1 true ES416929A1 (es) 1976-03-01

Family

ID=5851155

Family Applications (1)

Application Number Title Priority Date Filing Date
ES416929A Expired ES416929A1 (es) 1972-07-20 1973-07-14 Procedimiento para la preparacion de derivados de 1-(3-(5, 6,7,8-tetrahidronaft-1-il-oxi)-propil)-piperazina.

Country Status (14)

Country Link
US (1) US3947446A (US20020167097A1-20021114-C00005.png)
JP (1) JPS5331158B2 (US20020167097A1-20021114-C00005.png)
AR (1) AR196775A1 (US20020167097A1-20021114-C00005.png)
AT (1) AT330188B (US20020167097A1-20021114-C00005.png)
CA (1) CA1003836A (US20020167097A1-20021114-C00005.png)
CH (2) CH583721A5 (US20020167097A1-20021114-C00005.png)
DD (1) DD106842A5 (US20020167097A1-20021114-C00005.png)
DE (1) DE2235597A1 (US20020167097A1-20021114-C00005.png)
ES (1) ES416929A1 (US20020167097A1-20021114-C00005.png)
FR (1) FR2193598B1 (US20020167097A1-20021114-C00005.png)
GB (1) GB1376588A (US20020167097A1-20021114-C00005.png)
HU (1) HU165887B (US20020167097A1-20021114-C00005.png)
NL (1) NL149168B (US20020167097A1-20021114-C00005.png)
ZA (1) ZA734811B (US20020167097A1-20021114-C00005.png)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL175059C (nl) * 1974-02-23 Boehringer Mannheim Gmbh Bereiding van bloeddrukverlagende stoffen en van preparaten die ze bevatten.
DE2658762A1 (de) * 1976-12-24 1978-06-29 Hoechst Ag Neue o-alkylierte oxime, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
GB1583372A (en) * 1977-04-04 1981-01-28 Degussa 1-(3-(3,4,5-trimethoxyphenoxy)-2-hydroxypropyl)-4-aryl piperazine derivatives
US4101723A (en) * 1977-04-05 1978-07-18 E. R. Squibb & Sons, Inc. Substituted piperazinopropanols
US4259327A (en) * 1979-04-02 1981-03-31 Merck & Co., Inc. Substituted aminoalkoxypyridines, compositions and use thereof
US4255426A (en) * 1979-07-09 1981-03-10 Pfizer Inc. 1-(2-Hydroxy-3-n-alkoxypropyl)-4-substituted-piperazines and piperidines
DE3918542A1 (de) * 1989-06-07 1990-12-13 Boehringer Mannheim Gmbh Hydroxylierte 1-phenyl-4-(3-(napthth-1-yl-oxy)-2-hydroxy -propyl)-piperazine, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
IT1255178B (it) * 1992-06-26 1995-10-20 Pierrel Spa N(eter0)-aril-n(etero)-tetralinalchil piperazine aventi attivita' serotoninergica,dopaminergica e adrenergica
CA2332275A1 (en) * 1998-05-14 1999-11-18 Zoltan Tamas Nagy Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
EP1425261A2 (de) * 2001-08-31 2004-06-09 Bayer Chemicals AG Verfahren zur herstellung von 4-amino-1-naphtholethern

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1317034A (en) * 1970-11-06 1973-05-16 Pfizer Ltd 1-2-hydroxy-3-phenoxy- or -phenylthiopropyl-piperazine derivatives

Also Published As

Publication number Publication date
US3947446A (en) 1976-03-30
FR2193598A1 (US20020167097A1-20021114-C00005.png) 1974-02-22
DD106842A5 (US20020167097A1-20021114-C00005.png) 1974-07-05
JPS4943990A (US20020167097A1-20021114-C00005.png) 1974-04-25
FR2193598B1 (US20020167097A1-20021114-C00005.png) 1977-07-15
HU165887B (US20020167097A1-20021114-C00005.png) 1974-12-28
AR196775A1 (es) 1974-02-19
CH583722A5 (US20020167097A1-20021114-C00005.png) 1977-01-14
AT330188B (de) 1976-06-25
ZA734811B (en) 1974-07-31
NL149168B (nl) 1976-04-15
CA1003836A (en) 1977-01-18
DE2235597A1 (de) 1974-01-31
NL7310041A (US20020167097A1-20021114-C00005.png) 1974-01-22
GB1376588A (en) 1974-12-04
CH583721A5 (US20020167097A1-20021114-C00005.png) 1977-01-14
JPS5331158B2 (US20020167097A1-20021114-C00005.png) 1978-08-31
ATA636673A (de) 1975-09-15

Similar Documents

Publication Publication Date Title
ES434829A1 (es) Procedimiento para la preparacion de derivados de 1-(3-( naft-1-il-oxi)2-hidroxipropil)-piperazina.
MY102016A (en) Thiazolidinedione derivatives, their production and use.
ES416929A1 (es) Procedimiento para la preparacion de derivados de 1-(3-(5, 6,7,8-tetrahidronaft-1-il-oxi)-propil)-piperazina.
ATE206611T1 (de) Verwendung von mangiferin oder seinen derivaten zur kosmetischen anwendung
TR200001973T2 (tr) 11 ß-halojen-7alfa-ile ikame edilmiş-estratrienler, bu 11ß-halojen-7alfa-ile ikame edilmiş-estratrienleri içeren farmasötik terkiplerin üretimi için yöntem ve ilaç üretiminde kullanımları.
ES419687A1 (es) Procedimiento de preparacion de 1-(3-4metaclorofenil-1-pi- perazini) - propil-4, dictil-1,2-4-triazolin-5-ona.
ES430709A1 (es) Procedimiento para la obtencion de un medio fungicida a ba-se de derivados de 1-propil-imidazol.
NZ515304A (en) Bradykinin receptor antagonists
ES436312A1 (es) Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3-alquinilaminopropanos.
SE7612064L (sv) Dipeptidderivat, salter derav och forfarande for metning av enzymaktivitet
ES8105282A1 (es) Procedimiento para la obtencion de 2-dihalogenometilen-3-ha-logeno-3-carboalcoxi-5-oxopirrolidinas,utilizables como pa- rasiticidas fungicidas,bactericidas y alguicidas
SE8405588D0 (sv) New compounds
ES441616A1 (es) Un procedimiento para la preparacion de anilinobenzotiazo- les.
JO1629B1 (en) Andadnodol compounds i
MY102270A (en) New furanuronic acid derivatives, process their production and their use.
ES371297A1 (es) Procedimiento para la obtencion de 4-ciano-4-fenil-aminoci-clohexanos.
ES388879A1 (es) Procedimiento para la preparacion de 1-(2-nitrilofenoxi)-2-hidroxi-3-etilaminopropano racemico u opticamente activo.
ES8105711A1 (es) Un metodo de preparar derivados de piperidina
NO870423L (no) 5-substituerte oktahydroindolizin-analgetiske forbindelser og 7-keto mellomprodukter.
ES416614A1 (es) Procedimiento de preparacion de (benzoil-2et-1'-il)-1-(ci- namil-4''-piperazin-1''-il-metil)-2-bencimidazoles.
ES408605A1 (es) Procedimiento para preparar oxazoles 2,4,5-trisustituidos.
GB1435486A (en) 1-3-naphth-1-yloxy-propyl-piperazine derivatives
ES453932A1 (es) Procedimiento para la preparacion de nuevas 1-fenil-propil (2)-piperazinas racemicas u opticamente activas.
ES400453A1 (es) Procedimiento para la obtencion de derivados de n-acil-(pi-perazinoalquil)-pirazol.
FR2313064A1 (fr) Derives de l'(indenyloxymethyl)-2-morpholine